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Abstract

Background
Congenital heart disease (CHD) is the most common birth defect and affects almost 1%
of all live births. Treatment anxiety is common among children with CHD who undergo
multiple procedures early in their lifetime. Dramatically increased life spans for this cardiac
population has led to a shift from focusing on survival to their long-term health outcomes.
Methods:
Administration of the Peds QL Cardiac Module 3.0 assesses health related quality of life
(HRQOL) during annual visits to a Cardiac Neurodevelopmental (ND) Clinic by evaluating the
level of Treatment Anxiety a patient experiences during healthcare appointments. The
questionnaire scores are inversely rated, with higher scores correlating to less Treatment
Anxiety. Patients and parents/guardians received targeted education on treatment anxiety, its
causes, coping tools, and resources. Pre/post measures of treatment anxiety were measured.
Findings:
There were 7 children aged 5-17 years old enrolled over a period of three months. All but
one had measurably decreased treatment anxiety after the intervention. Almost every parent
endorsed feelings of being heard and gratitude for the education intervention as well.
Discussion:
This project is a simple, yet effective demonstration that proper education can positively
influence pediatric patient outcomes. Focusing on mental health and long-term outcomes for
patients with CHD is important and achievable during annual ND appointments.
Application to Practice:
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Implementing age-appropriate education on treatment anxiety and coping mechanisms
during ND visits is feasible and cost-saving, improving improves short- and long-term outcomes
for mental health in congenital cardiac patients. More research is needed for longer term
outcomes with these interventions.

EBP PROJECT TREATMENT ANXIETY

4

EBP Project: Treatment anxiety education for pediatric Cardiac
Neurodevelopmental patients
Clinical Problem
Congenital heart disease (CHD) is the most common birth defect, affecting almost
1% of all live births (Kaugers et al., 2017). In the United States alone, over 35,000 infants are
born annually with CHD, and more than a third of these infants have complex CHD (Wernovsky
et al., 2018). There are a wide range of defects and severity; many children are subject to
lifelong treatment and monitoring, which can include surgical intervention in infancy.
Fortunately, over the past few decades, mortality in this population has significantly improved,
yet not all health outcomes have had such progress (Wilmot et al., 2015). There are currently
over one million adults living in the US with many types of CHDs, with an estimated 150,000
adults with complex CHD (Wernovsky et al., 2018).
This increased survival rate and life expectancy has resulted in identification of new
comorbidities for this patient population, including mental health disorders and
neurodevelopmental delays (Uzark et al., 2008; Wilmot et al., 2015). There are many factors
that impact the presence of anxiety, depression, and ADHD in addition to neurodevelopmental
delays (NDDs) for children and adolescents through adulthood with CHD. Some of these risk
factors include the presence of underlying genetic syndromes, previous surgeries, familial mental
health disorders, time on cardiopulmonary bypass, prematurity, and prolonged hospitalization
(Gonzalez et al., 2021). According to Gonzalez et al. (2021), 50-75% of children with complex
CHD, such as single ventricle physiology, deal with NDDs and a subsequent reduction in quality
of life. These mental health comorbidities and developmental issues can lead to significant
lifelong problems for this cardiac population.
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Problem Clarification
The general population of 2 to 11-year-olds have a national prevalence of anxiety and
depression of 3 and 7% respectively (Gonzalez et al., 2021). In contrast, patients with CHD
were found to have a much higher prevalence (16%) of anxiety and/or depression diagnosis
(Gonzalez et al., 2021). Adolescents with CHD have more than double the likelihood of anxiety
and/or depression when compared with other adolescents without CHD (Gonzalez et al., 2021).
Anxiety prevalence is important because the presence of anxiety is directly related to reduced
Pediatric Cardiac Quality of Life Inventory scores (Marino et al., 2012).
Treatment anxiety or procedural anxiety is common among pediatric patients and
especially for children with special health care needs like CHD who have experienced multiple
surgeries or procedures (Goldman-Luthy, 2019). Treatment anxiety can be defined as “the fear
or worry related to any medical procedure that can interfere with your ability to receive
appropriate medical care” (“Procedural anxiety,” n.d.). Procedural anxiety stems from fear of
pain, which may be perceived or real, or from the memory of previous negative experiences
(Goldman-Luthy, 2019). The scope of procedures that induce anxiety can greatly vary, anything
from a routine diaper change to invasive interventional procedures (Goldman-Luthy, 2019). This
matter is important because it affects not only the patient but the whole family unit.
Substantial progress in medical and surgical care has drastically extended the life
expectancy for children born with CHD; now almost 90% of children with CHD end up
surviving to adulthood (Uzark et al., 2008). With these exciting advances, the focus of care
needs to shift beyond just survival and to long term health outcomes in this developing
population. Quality of Life and health related measures have become the emphasis for
healthcare promotion in cardiac patients (Uzark et al., 2008). Pediatric mental health has also
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been highlighted greatly recently, in the context of the past few years and as a result of the
Covid-19 pandemic. According to the American Heart Association, “periodic developmental
surveillance, screening, evaluation, and reevaluation throughout childhood may enhance
identification of significant deficits, allowing for appropriate therapies and education to enhance
later academic, behavioral, psychosocial, and adaptive functioning” (Marino et al., 2012, p.
1143).
Utilizing specific management protocols, such as family education or proper referrals,
can improve the efficacy of Health-related quality of life (HRQOL) surveillance and better
patient health (Varni et al., 2005). The PedsQL 3.0 Cardiac Module consists of a 27-item
questionnaire that has 6 themes: Heart problems and treatment, Treatment II, Perceived physical
appearance, treatment anxiety, cognitive problems, and communication. This project’s focus
was the Treatment Anxiety questionnaire and subsequent scores which consisted of 4 questions
rated on a 5-point Likert scale. These scores are inversely rated, with higher scores correlating to
less Treatment Anxiety. This survey is a HRQOL measuring tool and suited to this pediatric
cardiac population.
Summary of Evidence
In searching for evidence related to the treatment anxiety and HRQOL measures, clinical
databases such as CINAHL, Cochrane, and PubMed were utilized. Keywords such as “treatment
anxiety”, “Health Related Quality of Life”, “pediatric”, and “congenital heart disease” were used
in the search. In total, 13 articles were selected and reviewed, including clinical practice
guidelines, cross sectional surveys and prospective studies. Two articles described treatment
anxiety, its prevalence in children, and its implications for receiving medical care. Four of the
articles recognized the significance of the clinical problem in addition to identifying current gaps
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in the literature. Another two studies discussed outcomes related to pediatric mental health, and
a third detailed the annual costs of anxiety and depression in children with special health needs.
A comparative cross-sectional study of over 1100 patients found that a significant
number of youth with CHD have higher rates of mental health disorders and that screening this
population for anxiety and depression disorders is indicated (Gonzalez et al., 2021). Two studies
found the Peds QL Cardiac Module 3.0 to be feasible, reliable, and valid in assessing HRQOL in
pediatric patients with CHD (Uzark et al., 2003; Varni et al., 2005). According to Uzark et al.
(2008), children with CHD report lower quality of life than healthy children in all age groups.
Strengths and Limitations:
In reviewing the current literature for management of treatment anxiety, there are both
strengths and limitations present. In recent decades, growing attention has turned to the mental
health crisis in youth, with much more time and research devoted. Due to the burden associated
with anxiety and depression and their added morbidity throughout life, managing mental health
has become an increasing priority in primary care (Pella et al., 2020). The existing depth and
breadth of research on the impact of anxiety and depression on HRQOL, costs, and solutions is
substantial. This evidence is wide-ranging and integral to creating this EBP project on treatment
anxiety.
Unfortunately, there are also limitations associated with the research on
mental health illness and HRQOL indicators. There is no meta-analysis or systematic review
included in my literature review of this subject. The lack of a comprehensive article such as a
systematic review suggests that there is a solid foundation of research for this clinical problem,
but there is insufficient data and evidence thus far on interventions and clinical outcomes for
mental health disorders in this specific population. Multiple articles also cite limitations due to

EBP PROJECT TREATMENT ANXIETY

8

small populations and lack of diversity in their participants (Kaugers et al., 2017; Pella et al.,
2020; Uzark et al., 2008). Many of the studies only focused on patients with one or two specific
cardiac defects such as single ventricle physiology; in reality, there is a wide range of CHDs that
affect this cardiac population (Gonzalez et al., 2021; Kaugers et al., 2017). Research in the
future should focus on youth of all backgrounds, income classes, and with a range of cardiac
defects.
Evidence Based Intervention
This project focused on screening for treatment anxiety in pediatric patients with cardiac
defects being seen at the Cardiac Neurodevelopmental Clinic of a large, regional, pediatric
referral hospital. The purpose of this outpatient clinic is to evaluate the growth and development
of infants and young children with congenital heart disease. Risk reduction through early
identification and treatment of multisystem problems is important for successful development
and improved quality of life. Since quality of life cannot be exactly gathered from clinical or
laboratory results, optimizing health related interventions and outcomes depends on proven
measures for evaluating quality of life (Uzark et al., 2003). The literature, as previously stated,
supports the validity and reliability of the Peds QL Cardiac Module 3.0 for this patient
population. This is a valid and reliable measuring tool for HRQOL in this population.
The capability of an instrument to impact both clinical practice and patient outcomes
derives from the measuring tool’s effect on clinical decisions (Uzark et al., 2003). Screening this
group of patients for treatment anxiety is one of the evidence-based interventions in this project.
Regardless of the treatment anxiety score, all patients and families were given an informative
handout and educated on treatment anxiety background, coping mechanisms, and symptoms
during a detailed discussion. The patient education is the project’s second and more significant
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intervention. The primary outcome from this project is the treatment anxiety score from the Peds
QL Module; the project’s overall objective is to improve these scores after a short, uniform
education piece.
Gap Analysis
This Cardiac Neurodevelopmental Clinic was started in February 2020 as a transition for
patients from the High Risk Infant Follow-up Clinic. The focus of this new clinic is to evaluate
and monitor the neurodevelopmental outcomes of cardiac patients annually from childhood
through adolescence. The Peds QL Cardiac Module 3.0 was already being administered during
these appointments prior to this DNP Project. A considerable gap was present, due to the
novelty of this clinic. An experienced Nurse Practitioner identified an opportunity for this EBP
Project regarding treatment anxiety. On the Peds QL assessment, the treatment anxiety section
regularly scored low for these patients. Additionally, parents were voicing concerns over patient
anxiety during medical procedures and regular appointments. This project capitalizes on the
intersection of the movements towards neurodevelopmental outcomes in cardiac patients, mental
health, and patient centered care.
PICOT Clinical Question
At a Cardiac Neurodevelopmental clinic in the patient population ages 5-18 years old,
does administering the Peds QL Cardiac Module 3.0 improve education and support for
treatment anxiety in a 6-month period?
Nursing Theory and EBP Model
For this project, Virginia Henderson’s Nursing Need Theory applies comprehensively.
This nursing theory emphasizes the significance of supporting the patient to their utmost health
and independence (Ahtisham & Jacoline, 2015). Fourteen vital activities were composed for the
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nurse to help carry out, all based on basic human needs. Henderson’s approach is holistic and
includes components such as physiological, psychological, spiritual, and social (“Henderson’s
Nursing Need,” 2019). The ultimate goal utilizing these nursing activities is to help the person
reach their full independence. This theory fits well with this project because it encourages nurses
to promote health and illness prevention. Giving patients and families the tools to manage
treatment anxiety applies the essential components of communicating with others in expressing
emotions, needs, fears or opinions. As a Pediatric Nurse Practitioner, assisting patients with their
growth and eventual functional independence in their own healthcare is the core of meeting the
patient’s needs for this Need Theory.
The Stetler Model of Evidence-Based Practice served as the framework for the
implementation of EBP into this project. Advanced Practice RNs (APRNs) utilize this model
when creating new protocols and in innovative nursing led programs that originate from research
and the most up to date practice evidence (Melnyk & Fineout-Overholt, 2015). The Stetler
Model is frequently employed in advancing current practices and interventions to improve
patient outcomes in many settings such as primary care clinics. The five steps of this model are
both straightforward and user friendly for a wide range of clinical uses. These steps outlined as
Preparation, Validation, Comparative Evaluation or decision making, Translation or application,
and Evaluation. The Stetler Model optimized this project through the use of its key features of
simplicity and practitioner focus. The most current evidence of treatment anxiety screening and
education was collected and validated through the literature review.
Project Implementation
This project to screen and educate both patients and families on treatment anxiety
administered the Peds QL Cardiac Module 3.0 to patients from 5 to 18 years old. These
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recruited patients had pre-existing appointments at the Cardiac Neurodevelopmental (ND) Clinic
(in person or via Telehealth) with its Nurse Practitioner. This questionnaire is valid and reliable
for this patient population. After a stakeholder meeting, which had representatives from the
Cardiology Clinic, Research Team, and the Heart Center at the pediatric hospital, there was
collective support from management and staff for project implementation. The intervention
consisted of formalized treatment anxiety education and handout during the Cardiac ND
appointment or on a follow-up phone call to the family after screening for treatment anxiety.
Patient education included a 3-5 minute discussion with an informative handout on treatment
anxiety, coping mechanisms, and resources for the patient and family. Once the education was
complete, the parents answered the same questions from the Peds QL Cardiac Module 3.0 after
any following medical appointment to trend the treatment anxiety scores pre- and post-education.
The project’s focus is on the treatment anxiety scores of the Peds QL Cardiac Module 3.0. All
patients received education and supportive materials on treatment anxiety following completion
of the Peds QL Cardiac Module 3.0.
The primary outcome measures are the treatment anxiety scores. Secondary outcome
measures include patient and parent satisfaction and HRQOL. There were minimal costs
associated with this project. There was no additional staff education necessary beyond the
clinic’s sole Nurse Practitioner, and the other financial cost was for printing family handouts. At
the project’s finish, a stakeholder presentation with the same members was held; this meeting
discussed the positive effects of treatment anxiety education in pediatric cardiac patients. This
education session covered the problem of anxiety in this population, benefits of managing
treatment anxiety, and family feedback on feeling heard and having open discussions on this
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topic. This education is cost effective due to reduction in anxiety and improved long term
neurodevelopmental outcomes for this patient population.
This evidenced based project received IRB approval from the UCSD Human Research
Protections Program on December 7th, 2020. IRB approval through the USD Hahn School of
Nursing for this EBP Project was obtained on December 11, 2020. Once approved, patients were
retroactively recruited from an 8-month period and their Treatment Anxiety scores were accessed
through EPIC patient charts. The first set of scores was predominantly taken from patient charts.
The follow-up period for education, additional appointments and second administration of the
scoring was completed over a 3-month period (Dec 2020-Feb 2021). During the follow-up
period, a qualitative parental assessment on their feelings of satisfaction and sense of control in
care was done as well. Data analysis and evaluation of this project will be discussed in the
following section.
Evaluation Plan
Evaluating the outcomes from this project’s intervention is one of the utmost important
steps. There were 7 patients enrolled in this project, with 4 females and 3 males. The ages
ranged from 5-17 years old with an average age of 9. See Figures 1 and 2 for results and patient
scores. Overall, the scores from the questions pulled from the Treatment Anxiety section of the
Peds QL Cardiac Module 3.0 increased after providing education. The average score from
before the appointment was 57.14; after the project intervention, the average score increased to
68.75. Of all the participants, all but one score increased after age-appropriate patient education
was administered. Although this project was completed on a small scale, these results are
promising that this intervention makes a meaningful difference almost immediately for these
patients during their healthcare related appointments.
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Figure 1
Pre & Post Treatment Anxiety Education Average Scores
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Individual Pre & Post Treatment Anxiety Education Scores
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Patient Specific Scores
Another outcome that was followed was parent satisfaction. This secondary outcome
was assessed during the follow-up phone call to the parent. Almost all of the parents endorsed
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feelings of being heard, gratitude for being given the opportunity to talk about this undervalued
topic, and confidence for future appointments based on techniques and resources they learned
about through the education intervention. Family satisfaction during visits with providers is an
important metric measured frequently in outpatient clinics. This project shows that treatment
anxiety is a topic patients and families do value having a discussion about, and it can only
improve satisfaction scores.
Because the patient education is already formalized in a handout and the Peds QL
Cardiac Module 3.0 is integrated into the patient intake forms, this intervention will be relatively
simple to continue moving forward in this clinic. The intervention was easy to implement and
management support was not difficult to obtain at the start of the project. Once IRB approval
was granted, the project was executed quickly. No major modifications to the intervention are
necessary to reimplement in a new cycle for another round of larger data collection. A possible
barrier to continued implementation can be provider time during the patient visit. Although this
education only takes 3-5 minutes, it can be overlooked at the end of the appointment.
Additionally, these CHD patients are very complex and there may not be time during the visit to
properly teach about Treatment Anxiety. Another barrier could be no shows; during the Covid19 pandemic, many patients have not shown up to appointments or continually push back and
reschedule their annual ND visit.
Cost Benefit Analysis
The annual cost of pediatric anxiety disorder in the United States in the school age
population is $6405 (Pella et al., 2020). This cost includes direct and indirect factors such as
mental health services utilized, counseling, children’s missed school and parents’ missed work
(Pella et al., 2020). Additionally, the higher average costs were correlated with greater child
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anxiety and depression severity (Pella et al., 2020). Analysis of mental health illness financial
costs only further demonstrates how important this issue is to screen for and treat. The economic
burden of anxiety among other concerns necessitates improved access to mental health services
by promoting care in places with fewer barriers such as in primary care (Pella et al., 2020).
The costs associated with this EBP Project include recurring costs of extra time spent
during office visit completing the Treatment Anxiety education and funds for printing
educational handouts for families. Other costs and contributions in kind consist of support for
the project from Cardiology clinic staff, managers, and providers and technology used
(telephone, computers, EHR access). Taken as a whole, these costs to carry out the project are
minimal. There is significant cost avoidance for patients that have appropriately managed
anxiety. Depending on severity of illness, there can be a cost-savings of up to $6405 per child
annually. This project improved the treatment anxiety of 6 children in a 6-month period. The
cost savings of 6 children per annum is $38,430. For every dollar spent for this project, there is a
potential $294.03 cost savings.
Additional positive consequences include reduced risk for co-morbid conditions such as
concurrent depression, weight gain, or acquired cognitive deficits. Another advantage is
improved service to patients and families with implementation of focused education during
appointments. This also leads to increased satisfaction from providers due to connecting with
patients and families during visits as well as improved provider communication with patients and
families. A last intangible benefit lies in appreciation from both patients and families for
relevant information and optimal care.
Implications for Clinical Practice
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Implementing age-appropriate education on treatment anxiety and coping mechanisms
during ND visits is both feasible and cost-saving. An increase in HRQOL scores improves shortand long-term outcomes for mental health in congenital cardiac patients. Family satisfaction
with the pediatric clinic increases due to feeling heard and addressing unrecognized needs. A
future opportunity for this project is for the patient education to be translated into Spanish and
other languages to reach a wider patient population. In Southern California there is a large
Spanish speaking population. There are multiple ways to further this initial project moving
forward in Neurodevelopmental Clinics. Overall, proactive steps to identify, screen, and manage
treatment anxiety in children with CHD leads to better outcomes for both the patient and family.
Conclusion
Increasing amounts of research show that mental health issues, including treatment
anxiety, for pediatric CHD patients are a growing problem in the United States. With Congenital
Heart Defects being the number one birth defect, there will be no shortage of future patients in
the coming years. As much advancement in mortality outcomes as the medical field has had, it
is time to focus on the HRQOL outcomes for these aging children. This project demonstrates
that with properly implemented interventions, treatment anxiety can be reduced in the pediatric
CHD population.
This project is a simple, yet effective demonstration that proper education can positively
influence pediatric patient outcomes. Focusing on mental health and long-term outcomes for
patients with CHD is significant and achievable during annual ND appointments. Instituting a
standard protocol that includes the Peds QL Cardiac Module 3.0 and formal education during
routine outpatient follow-ups could greatly benefit these patients. This intervention could easily
be done in any Cardiac Neurodevelopmental Clinic or Cardiology office. Benefits of reducing
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treatment anxiety and discussing mental health problems include improved overall health,
decreased rates of anxiety and depression, and improved school performance. More research on
this topic is needed for longer term outcomes with these interventions.
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